hair thinning on tirzepatide Loss: Timeline & What to Expect Does Zepbound Cause Hair Loss?

Some observational studies have suggested that people with type 2 diabetes treated with GLP-1 receptor agonists may have a lower risk of developing dementia compared to those on other glucose-lowering medications

Health Stat

This personalized approach aligns with PlexusDx's precision-wellness model: matching your medication, dosing strategy, and supplementation to your individual biology rather than applying a standard protocol to all patients

Unlike pure GLP-1 receptor agonists, Tirzepatide activates two types of receptors simultaneously to create a synergistic efect: GIP Receptor Activation: Enhances insulin secretion, improves insulin sensitivity, and may promote lipid metabolism